- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Less is More? New Study Indicates Less Invasive Treatment May Yield Better Results for Breast Cancer Patients
(CBS News) A new study out of Duke University suggests less invasive treatment for early stage breast cancer may increase survival. The Duke research team analyzed data from 112,154 women diagnosed with Stage 1 or Stage 2 breast cancer between 1990 and 2004. 61,771 of the women received lumpectomy and radiation and 50,383 had mastectomy without radiation.
The researchers found that within three years of diagnosis, breast cancer patients who underwent lumpectomy and radiation had higher survival rates than those who chose mastectomy. The study was based on observational data, so it hints at an association but does not necessarily prove that less invasive treatment is more effective than a mastectomy in the early stage of breast cancer.
Read the full story: http://cbsn.ws/T0x9KH
Source: CBS News
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
ACA Dependent Coverage Extension and Young Adults’ Substance-Associated ED Visits
September 15th 2025This study examines the impact of the Affordable Care Act (ACA) on substance-associated emergency department (ED) visits among young adults, revealing reduced alcohol-associated visits but unchanged opioid-associated visits.
Read More
